Up-to-date, cross-sectional, global: Grünecker delivers everything you need to know about the latest changes in the law, judgments, and trends. As one of the world’s most active IP law firms, we keep you in the loop.
The 2025 edition of IAM’s Guide to Life Sciences: Key Issues for Senior Life Sciences Executives features a new article by our patent experts Dr. Markus Grammel (patent attorney and partner),...
Partner Gero Maatz-Jansen was once again invited by Potomac Law Group partners Reza Mollaaghababa and Joseph Murphy to share his perspective on key aspects of European patent law. In this episode,...
The landscape of AI regulation in Europe evolves. Several foundational rules—such as the ban on certain prohibited AI practices (Article 5) and the promotion of AI literacy (Article 4) - have been...
Our partner Dr. Markus Grammel analyzes for GRUR Patent (published by C.H. Beck Verlag) the recent decision “Planungseinrichtung” (X ZR 92/22) by the German Federal Court of Justice (BGH), which...
In the current issue of pharmind (87, No. 4/2025; in German), Dr. Julia Traumann and Dr. Markus Grammel provide an in-depth analysis of the fundamental structure and early practical experience with...
The recent judgments by the Court of Justice of the European Union (CJEU) in BSH Hausgeräte GmbH v. Electrolux AB (C-339/22) and the Unified Patent Court (UPC) in FUJIFILM Corporation v. Kodak GmbH...
Dr. Julia Traumann HOT TOPIC: Supplementary Protection Certificates (SPC) Manufacturing Waiver pursuant to Article 5(2) b) of the Amended Regulation (EC) No. 469/2009 concerning the Supplementary...
Chapters I and II of the AI Regulation came into force on February 2nd, 2025. In addition to Article 4, which obliges providers and operators of AI systems to ensure AI expertise, Article 5 of the...
In the latest issue of the IAM Guides to Life Sciences: Key issues for senior life sciences executive 2024, an article by our patent specialists Dr. Markus Grammel (patent attorney and partner),...
Our UK Patent attorneys Dr. Jegannath Korukottu and Dr. Josephine Caneilles discuss the latest decision regarding Artificial Neural Networks (ANN).
Dr. Markus Grammel explains the new EPO practice regarding sequence listings that are filed with divisional applications.
Dr. Sabine Koch analyses the latest developments and advantages and disadvantages of communicating with the European Patent Office (EPO) via email.